|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating Activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation and amortization | |||||
| Amortization of operating lease right-of-use assets | |||||
| Stock based compensation | |||||
| Loss on disposal of fixed assets | |||||
| Stock based compensation | |||||
| Gain on change in fair value of warrant liability | |||||
| Amortization of debt discount | |||||
| (Gain) / Loss on disposal of fixed assets | |||||
| Stock-based compensation expense | |||||
| Gain on change in derivative liability | |||||
| Gain on change in fair value of warrant liability | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Prepaid expenses | |||||
| Other current assets | |||||
| Accounts payable and accrued liabilities | |||||
| Deferred revenue | |||||
| Management and directors' fees payable | |||||
| Operating lease liabilities | |||||
| Net Cash Used In Operating Activities | |||||
| Investing Activities: | |||||
| Purchases of property and equipment | |||||
| Purchase of license | |||||
| Net Cash Used In Investing Activities | |||||
| Financing Activities: | |||||
| Net proceeds from issuance of common shares | |||||
| Tax withholdings paid related to stock-based compensation | |||||
| Common stock repurchased | |||||
| Proceeds from grants repayable | |||||
| Proceeds from long-term debt | |||||
| Proceeds from issuance of Warrants | |||||
| Payments on long-term debt | |||||
| Payments on convertible loan note | |||||
| Payments on grants repayable | |||||
| Payments on financing leases | |||||
| Payments on financing leases | |||||
| Net Cash Provided By Financing Activities | |||||
| Effect of foreign exchange on cash and cash equivalents | |||||
| Net Change in Cash and Cash Equivalents | |||||
| Cash and Cash Equivalents - Beginning of Year | |||||
| Cash and Cash Equivalents - End of Year | |||||
| Supplemental Disclosures of Cash Flow Information: | |||||
| Cash paid for Interest | |||||
| Non-Cash Investing and Financing Activities: | |||||
| Common stock issued for settlement of vested RSUs | |||||
| Fair value of derivative liability recognized upon issuance of convertible note | |||||
| Issuance of warrants in connection with convertible note offering | |||||
| Debt issuance cost recognized upon issuance of convertible note | |||||
| Common stock issued for license rights | |||||
| Offering costs from issuance of common stock | |||||
| Fair value of warrants issued in connection with public offering at issuance | |||||
| Non-cash note payable | |||||
Loading...